Chinese Journal of Blood Purification ›› 2022, Vol. 21 ›› Issue (09): 664-667.doi: 10.3969/j.issn.1671-4091.2022.09.009

Previous Articles     Next Articles

Application of gabapentin in the treatment of hemodialysis patients 

LI Qing-lei, MENG Jian-zhong   

  1. 1Changle Weigao Hemodialysis Center, Changle District, Fuzhou City, Fujian Province,Changle 350000,China ;   2Department of Nephrology, 960th Hospital of Chinese People's Liberation Army,Jinan 250031, China
  • Received:2022-02-28 Revised:2022-05-31 Online:2022-09-12 Published:2022-09-06
  • Contact: LI Qing-lei E-mail:qinglei.li@shbaoshu.com

Abstract: With the higher prevalence and the longer survival of uremia patients in our country, the shortage of hemodialysis professionals prevails and accounts for the insufficiency of hemodialysis technologies in basic communities. The advanced assistant dialysis measures, such as high flux hemodialysis, hemoperfusion and drugs of expensive prices, are hardly to be adopted in several areas due to the different health insurance policies, causing dialysis inadequacy and hemodialysis complications in many patients in these areas. Gabapentin (GBP) has a better therapeutic effect in the treatment of many hemodialysis complications. We therefore searched the databases of PubMed and CNKI for the studies in recent years about GBP in the treatment of hemodialysis complications, including uremic pruritus, restless legs syndrome and uremic peripheral neuralgia. In this paper, we try to provide the therapeutic strategies against hemodialysis complications by using GBP for hemodialysis professionals.

Key words: Hemodialysis, Gabapentin, Uremic pruritus, Restless legs syndrome, Uremic peripheral neuralgia

CLC Number: